Core Points - AbbVie has announced the appointment of Robert A. Michael as the new CEO, succeeding Richard A. Gonzalez, who will now serve as executive chairman [1][2] - Robert A. Michael has extensive experience in various leadership roles within AbbVie, including president and chief operating officer, and has been part of the Executive Leadership Team for many years [2][3] - The transition in leadership is aimed at continuing AbbVie's mission to deliver innovative medicines and to drive the next phase of growth for the company [3][4] Company Overview - AbbVie's mission focuses on discovering and delivering innovative medicines that address serious health issues and future medical challenges across key therapeutic areas such as immunology, oncology, neuroscience, and eye care [4]
Robert A. Michael Assumes Role as AbbVie Chief Executive Officer